1. Current Top 3 holdings: $PLUG +27% $NQ -12% $KNDI +55% Other longs: $KORS +4% $CMG +11% $GALT +8% $NFLX +4% $QIHU +4% $INVN +22%

  2. $GALT Low volume, tight price action today. If $IBB and $RUT give support this one may be ready to run.

  3. Breakout stock for next week. $PLUG $GLUU $KNDI $GALT $TRLA $FB, Long $mnkd $dal $TSL. Should be fun next week.

  4. $RPTP NASH stocks: $GALT +11% $ICPT +4% $CNAT +3% $RPTP+2%. Underperformance, again and again

  5. $GALT Bearish under $12 http://y.ahoo.it/9b73bpA9

  6. $RPTP NASH stocks today modestly down-1%/-2% $ICPT $GALT $CNAT. $RPTP is down 8%

  7. $LJPC expected profit taking and shorting on open. Still undervalued when compared to $GALT

  8. $RPTP NASH stocks up today 3% to 7% $ICPT $GALT $CNAT

  9. $GALT Galectin Therapeutics Added to Russell 2000 Index.. http://y.ahoo.it/cNjXz6ie

  10. Watchlist 7/8/14 $EDAP $EGRX $ACRX $REGN $MNTA $GALT $ALKS $MDVN

  11. As we predicted, $IBB dragged down $GALT more than 6% in one day; click-through for our mitigation strategy/gloating http://y.ahoo.it/khz0UNJd

  12. @leslie_oconnell also $GALT $ACRX

  13. Insider and Institutional Bulls - 1 Month Return: 32.10% $SNSS $SKBI $ORMP $BCRX EOX $TPLM $SXE $ATRC $GALT $FSL

  14. $ICPT $GALT not much love, but nothing like the scorn of a rejected old lover careful on late shorts / puts

  15. $GALT over 1M vol. AH, 427k shares @ 14.14

  16. $GALT 14.22 short

  17. $RNN Slow day on RNN today, but you guys should check out $GALT. There s tremendous science validating this co. I m still investigating.

  18. Thursday s watch list for Intraday Shorts $GORO $BLDP $GALT $EOX $WWWW $CPE Pls see info & records at http://y.ahoo.it/PCSmjpII

  19. @ChartMill: #stocks new pocket pivots http://y.ahoo.it/d6NyDz52 $OMER $GALT $PTX

  20. #stocks new pocket pivots http://y.ahoo.it/lNYHIII2 $OMER $GALT $PTX

  21. @10handles $ICPT $GALT spent melting

  22. Is $GALT a BUY? Aegis Capital thinks so:http://y.ahoo.it/nNOWCobI

  23. Alert results: $ARTX +8% $COCO +8% $GALT +0% $GBR +1% $ICLD +0% $NSPH +2% $WLT +4%

  24. $galt +3% pre-market,oral treatment with Galectin-3 inhibitor GR-MD-02 efficacious in preclinical model of fatty liver disease

  25. $GALT Announces That Oral Treatment With Galectin-3 Inhibitor GR-MD-02 is Efficacious in Preclinical Model of Fatty Liver Disease.